BIOGEN INC. Deferred Income Tax 2007-2026 | BIIB
Beta
What is deferred income tax?
Deferred income tax represents the difference between income tax expense recognized on the income statement and the actual tax liability paid.
What is BIOGEN INC.'s current deferred income tax?
BIOGEN INC. (BIIB) annual deferred income tax for 2025 was $361.6M, a 328.72% increase from 2024. BIOGEN INC. deferred income tax for the quarter ending March 31, 2026 was $23.6M.
What was BIOGEN INC.'s deferred income tax in 2024?
BIOGEN INC. annual deferred income tax for 2024 was $-158.1M, a 48.30% increase from 2023.
What was BIOGEN INC.'s deferred income tax in 2023?
BIOGEN INC. annual deferred income tax for 2023 was $-305.8M, a 81.38% decline from 2022.
What is BIOGEN INC.'s 5-year deferred income tax CAGR?
BIOGEN INC. deferred income tax grew at a compound annual growth rate (CAGR) of 19.40% from FY2020 to FY2025, going from $149.0M to $361.6M over 5 years.
Deferred Income Tax History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+19.4%
FY2020
$149.0M
→
FY2025
$361.6M
07080910111213141516171819202122232425
5 years selected
Deferred Income Tax History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $361.6M | +328.7% | 10-K |
| FY2024 | $-158.1M | +48.3% | 10-K |
| FY2023 | $-305.8M | -81.4% | 10-K |
| FY2022 | $-168.6M | +60.5% | 10-K |
| FY2021 | $-426.8M | -386.4% | 10-K |
| FY2020 | $149.0M | +122.1% | 10-K |
| FY2019 | $67.1M | -38.0% | 10-K |
| FY2018 | $108.3M | +18.1% | 10-K |
| FY2017 | $91.7M | +152.4% | 10-K |
| FY2016 | $-175.0M | -20.2% | 10-K |
| FY2015 | $-145.6M | +52.8% | 10-K |
| FY2014 | $-308.2M | -25.7% | 10-K |
| FY2013 | $-245.1M | -109.7% | 10-K |
| FY2012 | $-116.9M | -176.1% | 10-K |
| FY2011 | $153.6M | +288.6% | 10-K |
| FY2010 | $-81.4M | +40.7% | 10-K |
| FY2009 | $-137.4M | +1.6% | 10-K |
| FY2008 | $-139.5M | -71.1% | 10-K |
| FY2007 | $-81.6M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →